Ulrich Dauer
Director/Board Member bij Atriva Therapeutics GmbH
Vermogen: 22 490 $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Clemens M. Doppler | M | 64 | 19 jaar | |
| Piet Wigerinck | M | 58 |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | - |
| Michael Schaeffer | M | 56 | 6 jaar | |
| Manfred Rüdiger | M | 59 | 19 jaar | |
| Helmut Jeggle | M | 53 | 16 jaar | |
| Christian Pangratz | M | - |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | 1 jaar |
| Samir Shah | M | 63 | 2 jaar | |
| Irina Antonijevic | M | 59 | 12 jaar | |
| Michael Grissinger | M | 70 |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | 4 jaar |
| Christian Wallasch | M | - |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | - |
| Claudia Riedl | M | 54 | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jörg Neermann | M | 57 | 12 jaar | |
| Dinnies Johannes von der Osten | M | 62 | 16 jaar | |
| Daniel Vitt | M | 55 | 19 jaar | |
| Enno Spillner | M | 55 | 11 jaar | |
| Roland Baumgartner | M | - | - | |
| Inge Lues | M | - | 10 jaar | |
| Florian Schmid | M | 50 | 3 jaar | |
| Günter Frankenne | M | - | 4 jaar | |
| Brian D. Morgan | M | - | - | |
| Bernd Hentsch | M | 64 | - | |
| Klaus Kühn | M | 72 | 2 jaar | |
| Stefan Busemann | M | - | - | |
| Manfred Gröppel | M | 55 | - | |
| Thomas Werner | M | 68 | 5 jaar | |
| Klaus-Peter Gulden | M | - | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Duitsland | 26 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Ulrich Dauer
- Persoonlijk netwerk
